These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 9653551
21. Active-site mutants of the VanC2 D-alanyl-D-serine ligase, characteristic of one vancomycin-resistant bacterial phenotype, revert towards wild-type D-alanyl-D-alanine ligases. Healy VL, Park IS, Walsh CT. Chem Biol; 1998 Apr; 5(4):197-207. PubMed ID: 9545431 [Abstract] [Full Text] [Related]
22. Absence of VanA- and VanB-containing enterococci in poultry raised on nonintensive production farms in Brazil. Batista Xavier D, Moreno Bernal FE, Titze-de-Almeida R. Appl Environ Microbiol; 2006 Apr; 72(4):3072-3. PubMed ID: 16598023 [Abstract] [Full Text] [Related]
23. Rotational-echo double resonance characterization of vancomycin binding sites in Staphylococcus aureus. Kim SJ, Cegelski L, Studelska DR, O'Connor RD, Mehta AK, Schaefer J. Biochemistry; 2002 Jun 04; 41(22):6967-77. PubMed ID: 12033929 [Abstract] [Full Text] [Related]
24. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Bugg TD, Wright GD, Dutka-Malen S, Arthur M, Courvalin P, Walsh CT. Biochemistry; 1991 Oct 29; 30(43):10408-15. PubMed ID: 1931965 [Abstract] [Full Text] [Related]
25. First description in Europe of the emergence of Enterococcus faecium ST117 carrying both vanA and vanB genes, isolated in Greece. Papagiannitsis CC, Malli E, Florou Z, Medvecky M, Sarrou S, Hrabak J, Petinaki E. J Glob Antimicrob Resist; 2017 Dec 29; 11():68-70. PubMed ID: 28754459 [Abstract] [Full Text] [Related]
26. Vancomycin analogs: Seeking improved binding of d-Ala-d-Ala and d-Ala-d-Lac peptides by side-chain and backbone modifications. Leung SS, Tirado-Rives J, Jorgensen WL. Bioorg Med Chem; 2009 Aug 15; 17(16):5874-86. PubMed ID: 19620008 [Abstract] [Full Text] [Related]
27. Mechanisms of glycopeptide resistance in enterococci. Arthur M, Reynolds PE, Depardieu F, Evers S, Dutka-Malen S, Quintiliani R, Courvalin P. J Infect; 1996 Jan 15; 32(1):11-6. PubMed ID: 8852545 [Abstract] [Full Text] [Related]
28. Characteristics of Vancomycin-Resistant Enterococcus Strains in the West Balkans: A First Report. Jakovac S, Bojić EF, Ibrišimović MA, Tutiš B, Ostojić M, Hukić M. Microb Drug Resist; 2017 Jan 15; 23(1):122-126. PubMed ID: 27351410 [Abstract] [Full Text] [Related]
29. Lipophilic teicoplanin pseudoaglycon derivatives are active against vancomycin- and teicoplanin-resistant enterococci. Szűcs Z, Bereczki I, Csávás M, Rőth E, Borbás A, Batta G, Ostorházi E, Szatmári R, Herczegh P. J Antibiot (Tokyo); 2017 May 15; 70(5):664-670. PubMed ID: 28144040 [Abstract] [Full Text] [Related]
30. Resistance to glycopeptide antibiotics in the teicoplanin producer is mediated by van gene homologue expression directing the synthesis of a modified cell wall peptidoglycan. Beltrametti F, Consolandi A, Carrano L, Bagatin F, Rossi R, Leoni L, Zennaro E, Selva E, Marinelli F. Antimicrob Agents Chemother; 2007 Apr 15; 51(4):1135-41. PubMed ID: 17220405 [Abstract] [Full Text] [Related]
31. vanA Gene Harboring Enterococcal and Non-enterococcal Isolates Expressing High Level Vancomycin and Teicoplanin Resistance Reservoired in Surface Waters. Nakipoğlu M, Yilmaz F, Icgen B. Bull Environ Contam Toxicol; 2017 May 15; 98(5):712-719. PubMed ID: 27770152 [Abstract] [Full Text] [Related]
32. Genetic characteristics of vancomycin resistance gene cluster in Enterococcus spp. Chen CH, Xu XG. Yi Chuan; 2015 May 15; 37(5):452-7. PubMed ID: 25998433 [Abstract] [Full Text] [Related]
33. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiramatsu K. J Antimicrob Chemother; 1998 Aug 15; 42(2):199-209. PubMed ID: 9738837 [Abstract] [Full Text] [Related]
34. Mechanism of action of oritavancin and related glycopeptide antibiotics. Allen NE, Nicas TI. FEMS Microbiol Rev; 2003 Jan 15; 26(5):511-32. PubMed ID: 12586393 [Abstract] [Full Text] [Related]
35. Vancomycin resistance in gram-positive cocci. Courvalin P. Clin Infect Dis; 2006 Jan 01; 42 Suppl 1():S25-34. PubMed ID: 16323116 [Abstract] [Full Text] [Related]
36. Genetics of glycopeptide resistance in enterococci. Evers S, Quintiliani R, Courvalin P. Microb Drug Resist; 1996 Jan 01; 2(2):219-23. PubMed ID: 9158763 [Abstract] [Full Text] [Related]
37. Katanosin B and plusbacin A(3), inhibitors of peptidoglycan synthesis in methicillin-resistant Staphylococcus aureus. Maki H, Miura K, Yamano Y. Antimicrob Agents Chemother; 2001 Jun 01; 45(6):1823-7. PubMed ID: 11353632 [Abstract] [Full Text] [Related]
38. Gain of D-alanyl-D-lactate or D-lactyl-D-alanine synthetase activities in three active-site mutants of the Escherichia coli D-alanyl-D-alanine ligase B. Park IS, Lin CH, Walsh CT. Biochemistry; 1996 Aug 13; 35(32):10464-71. PubMed ID: 8756703 [Abstract] [Full Text] [Related]
39. Sequence of the vanB and ddl genes encoding D-alanine:D-lactate and D-alanine:D-alanine ligases in vancomycin-resistant Enterococcus faecalis V583. Evers S, Reynolds PE, Courvalin P. Gene; 1994 Mar 11; 140(1):97-102. PubMed ID: 8125347 [Abstract] [Full Text] [Related]
40. The VANA glycopeptide resistance protein is related to D-alanyl-D-alanine ligase cell wall biosynthesis enzymes. Dutka-Malen S, Molinas C, Arthur M, Courvalin P. Mol Gen Genet; 1990 Dec 11; 224(3):364-72. PubMed ID: 2266943 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]